Review of docetaxel in the treatment of gastric cancer
Eric D Tetzlaff1, Jonathan D Cheng1, Jaffer A Ajani21Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA; 2Gastrointestinal Medical Oncology, M.D. Anderson Cancer Center, Houston, TX, USAAbstract: Gastric cancer is a global health problem accounting for 800,000 cancer related deaths ann...
Saved in:
Main Authors: | Eric D Tetzlaff (Author), Jonathan D Cheng (Author), Jaffer A Ajani (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
by: Putao Cen, et al.
Published: (2008) -
Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
by: Dipika S. Gaikwad, et al.
Published: (2023) -
Cooperative Treatment of Gastric Cancer Using B7-H7 siRNA and Docetaxel; How Could They Modify Their Effectiveness?
by: Nadia Bolandi, et al.
Published: (2023) -
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
by: Ke Li, et al.
Published: (2019) -
Docetaxel extravasation: Pathologic correlation and treatment with intralesional steroids
by: John W. Roman, MD, et al.
Published: (2017)